Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo.
Zheng
B
B
Department of Cardiovascular Surgery, Stanford University School of Medicine, California 94305-5247.
Shorthouse
R
R
Masek
M A
MA
Berry
G
G
Billingham
M E
ME
Morris
R E
RE
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D008213:Lymphocyte Activation / Q000187:drug effects; D008221:Lymphoid Tissue / Q000187:drug effects / Q000276:immunology*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D011090:Polyenes / Q000494:pharmacology*; D051381:Rats; D012016:Reference Values; D020123:Sirolimus; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D016559:Tacrolimus; D013950:Thymus Gland / Q000187:drug effects / Q000276:immunology
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus; D016559:Tacrolimus